Purification, characterization and receptor binding of haemopoietic cell growth factors
The essential starting points for an analysis of these molecules and their respective roles in haemopoiesis are their purification and characterization of biological activity. Several groups reported the isolation of specific haemopoietic growth factors with differing lineage restrictions and target cell population specificities. E. Goldwasser (University of Chicago USA) described the chemistry of purified erythropoietin, a key regulatory factor in erythropoiesis. This molecule is a glycoprotein (mol. wt 34,000) containing 24-31% carbohydrate which is essential for in vivo activity, but not in vitro biological activity. There are three domains, two protease resistant (containing all of the carbohydrate) joined by a third connecting region that contains the active region. This purified molecule can rapidly induce the transcription of globin mRNA in pure populations of late erythroid progenitor cells (CFU-e). To study receptor binding of erythropoietin Goldwasser used an erythroleukaemia cell line which produces haemoglobin in response to erythropoietin. He Significantly, murine radioiodinated G-CSF binds not only to cells of murine origin, but also to human granulocytic cells. Of the two types of human colony stimulating factors (CSF-ac, CSF-f) with some similar activities to murine G-CSF Nicola found that human CSF-,B completely inhibits the binding of murine G-CSF to both murine and human cells, whilst CSF-a had no such effect. CSF-,B and G-CSF also share all biological activities across the two species indicating that CSF-f may represent the human equivalent of murine G-CSF.
R. Shadduck (Monteflore Hospital, Pittsburgh USA) has also isolated and characterized a murine myeloid-lineage restricted growth factor known as CSF-l or macrophage-CSF. The murine M-CSF is a 60-70,000 mol. wt dimer of which > 50% is carbohydrate. Again an ability to bind specifically to the cell surface was demonstrated. Experiments with radioiodinated CSF-1 showed 5000 receptors per cell, the greater number of receptors being observed on blast and) mononuclear cells in normal murine bone marrow. Shadduck also described a human CSF-1 of mol.wt 60-64,000, isolated from urine. This is also a dimer, but unlike the G-CSF and CSF-f no cross species reactivity is observed.
The It was apparent from these contributions that a complex scheme involving both lineage restricted and multilineage haemopoietic growth factors is emerging. In addition some of these growth factors exhibit cross species reactivity, whilst others are unable to do so. Another important feature of these contributions was that the growth factors act at very low concentrations and in addition the receptor numbers per cell are extremely low. There is also intriguing evidence that very few receptors need be occupied to elicit a biological effect suggesting that a few molecules per cell can induce proliferation and differentiation.
Molecular cloning of haemopoietic growth factors Another route recently employed to obtain large quantities of pure haemopoietic growth factors is molecular cloning. A very clear account of cloning strategies was given by Drs T. Yokota and F. Lee (DNAX, California) who described the three important requisities as, firstly, a source of biologically active messenger RNA; secondly, a full length cDNA library in a mammalian expression vector; and thirdly reliable and sensitive biological assays. This strategy had been employed to good effect in their hands. to clone murine Interleukin 3 and also Interleukin 2 (T cell growth factor). Yokota described Interleukin 3 as a polypeptide consisting of 134 amino acid residues, mol. wt 15,000. The discrepancy between this and Ihle's 28,000 mol. wt could be accounted for by the sugar groups attached to the protein at the 4 potential Nglycosylation sites, although the N-terminal sequence which Ihle has reported from an amino acid analysis of the purified protein appears to be several residues shorter than the reported sequence from the DNAX and Canberra groups (obtained via molecular cloning), an anomaly which is at present unexplained. Biological activities of Interleukin 3 produced by transfected cos-7 monkey cells were shown to include all the activities characteristic of Interleukin 3.
A.R. Dunn (Ludwig Institute for Cancer Research, Melbourne) has also installed full length cDNA fragments of not only Interleukin-3 but also granulocyte-macrophage colony stimulating factor (GM-CSF) into a eukaryotic expression vector and transfected into simian cos cells where they direct the expression of growth factors with apparently normal biological characteristics. For the GM-CSF molecule Dunn and co-workers (after having obtained the cDNA sequence using a strategy similar to that described by Yokota and Lee), have considered the nucleotide sequence at the 5' end of GM-CSF messenger RNA. This reveals the presence of two AUG (initiation) codons associated with a stable loop structure both of which are in frame with the coding sequences of GM-CSF. Use of these 5' AUG codons would result in a nascent polypeptide with the characteristics of a transmembrane protein, whereas use of the second would result in the synthesis of a hydrophobic leader sequence characteristic of a secreted protein. This gives rise to the intriguing speculation that GM-CSF may, in some cases, exist as a membrane bound protein which can present itself to neighbouring cells only. This may .have important implications for the role of the stromal microenvironment in supporting haemopoiesis in that expression of growth factor activity at the membrane may play a key role in the cell: cell interactions, known to be of fundamental importance in haemopoiesis.
Using the sequences derived for GM-CSF and Interleukin 3, probes have been constructed (by both the DNAX and Melbourne groups) to identify a human counterpart to these murine molecules. However, both these groups have had little success in obtaining a human equivalent to Interleukin-3. On the other hand Lee (of DNAX) did report the identification of a human equivalent to murine GM-CSF whose biological activities were in the process of being tested.
Several important points arose from the work described by the molecular biologists. Firstly the molecular cloning of haemopoietic growth factors is possible and expression of biologically active growth factors can be achieved in both prokaryotic and eukaryotic systems. Second, it is apparent that the high degree of glycosylation found on many of these haemopoietic growth factors is not necessary for biological activity (this was reported by A.D.
Whetton (Paterson Laboratories, Manchester), who said that studies by L. Healey and G. W. Bazill (Paterson Laboratories, Manchester) had shown that highly purified Interleukin 3, isolated from WEHI-3B cell conditioned medium, retained full biological activity when stripped of its carbohydrate groups with endoglycosidase F). Third, although some growth factors exhibit some species conservation this is not always the case. Fourth, production of large amounts of molecularly cloned material is at the moment presenting something of a problem. No effective procedure has yet been found to yield large amounts of biologically active protein from transfected eukaryotic or prokaryotic cells. Fifth, the structure and expression of the growth factor genes and the possible form the protein can take (i.e. membrane bound or soluble) can now be explored much more readily with the sequence data obtained by molecular biological techniques.
Biological activities of haemopoietic growth factors
The range of activities and specificities of haemopoietic growth factors has been described to some extent but obviously many questions still remain. In particular how do all the regulatory molecules act together in vivo to maintain haemopoietic homeostasis and what are the events leading to disruption of haemopoiesis? Oncogenes have been implicated in growth regulation in many systems and their influence on the production of, and response to, haemopoietic growth factors is being investigated.
As in the murine and human systems, haemopoietic growth factors have been isolated from chickens. A. Leutz (EMBL, Heidelberg) described the purification of chicken myelomonocytic growth factor (cMGF), which has the ability to promote macrophage colony development from normal chicken bone marrow. This factor was also able to promote survival of cMGF-dependent chicken myeloblast cell lines that are produced following transformation by retroviruses encoding the v-myb and v-myc oncogenes. However, macrophages transformed by the MHZ virus were independent of cMGF for survival; the MHZ virus encodes both vmyc and the src-related v-mil. Leutz subsequently showed that the cMGF-dependent v-myb transformed myeloblasts could be rendered factorindependent by other src-related retroviral sequences (e.g. v-fps, v-yes, v-ros) but not by v-myc.
Similarly, v-src converted the factor-dependent vmyb transformed cells to independence, but not the v-myc transformed myeloblasts. The conversion to factor-independence is associated with the production of a cMGF-like substance by the cells, indicating the the survival of the cells requires autocrine stimulation. Experiments along similar lines, with mouse cell lines, were described by IhIe. In this case IL3-dependent cell lines were infected with molecular recombinants containing v-myc from MHZ or MC-29 viruses, resulting in factorindependence of the cell lines. In further contrast to Leutz's results these factor-independent cells retained the receptors for IL3 but did not themselves produce it, nor did antiserum to IL3 block the growth of the cells. This suggests that the requirement for normal growth factor had been bypassed in some way.
Another approach to investigating the possible role of oncogenes in the control of haemopoiesis was discussed by E. Spooncer (Paterson Laboratories, Manchester). Long-term bone marrow cultures were infected with virus containing the src oncogene which resulted in long-term and stable changes in the haemopoietic activity in the cultures, viz. an almost complete block in the output of mature cell types and a build up of primitive cell types. This was accompanied by the expression of apparently unlimited self-renewal capacity by the haemopoietic stem cells. Furthermore, it was possible to derive cell lines from these cultures which were dependent on IL3 for their survival, were non-leukaemic and possessed many of the characteristics of the stem cell. The role of the oncogene in the transformation of haemopoietic activity following infection with src is not quite clear. Due to the failure to detect the src kinase activity specifically associated with cells of haemopoietic origin there is a possibility that these effects may have been mediated via a direct influence of the src oncogene on stromal cells of the haemopoietic environment, which subsequently resulted in a modification of haemopoietic activity. These studies showed diverse influences of v-oncogenes on haemopoiesis in promoting the emergence of factordependent cell lines; factor-independent cell lines which appear either to produce their own supply of IL3 or to be totally autonomous of normal growth regulation and in permitting extensive self-renewal of stem cells. This raises the question of whether analogous c-oncogenes are, in fact, involved in the control of normal haemopoietic cell development in response to growth factors.
Some progress has recently been made in describing, in biochemical terms, the nature of dependence of haemopoietic cells on IL3. Whetton demonstrated a chain of biochemical events which IL3-dependent cell lines undergo in response to IL3, but not in response to any other, non-specific, growth factors. In the presence of IL3, intracellular ATP levels are maintained in the cells. In its absence ATP levels rapidly fall. In fact limited survival of the cells could be effected by an ATPregenerating system in the absence of IL3. The IL3 was shown to be acting on the ATP-generating machinery of the cell at the level of glycolysis and the point of regulation of this process is the transport of glucose into the cell by the glucose transport protein. Presumably the binding of IL3 to its receptor activates (directly or indirectly) the glucose transport mechanism and the subsequent production of ATP by glycolysis ensures survival of the cell. The requirement for some step in this chain of events is clearly bypassed in the case of the factor-independent cell lines described by Ihle and such cell lines should permit determination of the biochemical changes that lead to the emergence of autonomous haemopoietic cells.
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